Alexandre Chappard

Alexandre Chappard

Auto-generated profile, based on publicly available information

Alexandre Chappard

EaStCHEM School of Chemistry The University of Edinburgh Edinburgh EH9 3FJ UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
MCMinee L. Choi
Minee L. Choi
ACAlexandre Chappard
Alexandre Chappard
BSBhanu P. Singh
Bhanu P. Singh
CMCatherine Maclachlan
Catherine Maclachlan
MRMargarida Rodrigues
Margarida Rodrigues
SGSonia Gandhi
Sonia Gandhi
Aggregation of alpha-synuclein (α-Syn) drives Parkinson’s disease (PD), although the initial stages of self-assembly and structural conversion have not been directly observed inside neurons. In this study, we tracked the intracellular conformational states of α-Syn using a single-molecule Förster resonance energy transfer (smFRET) biosensor, and we show here that α-Syn converts from a monomeric state into two distinct oligomeric states in neurons in a concentration-dependent and sequence-specific manner. Three-dimensional FRET-correlative light and electron microscopy (FRET-CLEM) revealed that intracellular seeding events occur preferentially on membrane surfaces, especially at mitochondrial membranes. The mitochondrial lipid cardiolipin triggers rapid oligomerization of A53T α-Syn, and cardiolipin is sequestered within aggregating lipid–protein complexes. Mitochondrial aggregates impair complex I activity and increase mitochondrial reactive oxygen species (ROS) generation, which accelerates the oligomerization of A53T α-Syn and causes permeabilization of mitochondrial membranes and cell death. These processes were also observed in induced pluripotent stem cell (iPSC)–derived neurons harboring A53T mutations from patients with PD. Our study highlights a mechanism of de novo α-Syn oligomerization at mitochondrial membranes and subsequent neuronal toxicity.

23 September 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
ALAndré D. G. Leitão
André D. G. Leitão
PRPaulina Rudolffi-Soto
Paulina Rudolffi-Soto
ACAlexandre Chappard
Alexandre Chappard
ABAkshay Bhumkar
Akshay Bhumkar
DLDerrick Lau
Derrick Lau
Emma SiereckiEmma Sierecki
Emma Sierecki
The aggregation of alpha-synuclein (α-SYN) follows a cascade of oligomeric, prefibrillar and fibrillar forms, culminating in the formation of Lewy Bodies (LB), the pathological hallmarks of Parkinson’s Disease. Although LB contain over 70 proteins, the potential for interactions along the aggregation pathway of α-SYN is unknown. Here we propose a map of interactions of 65 proteins against different species of α-SYN. We measured binding to monomeric α-SYN using AlphaScreen, a sensitive nano-bead luminescence assay for detection of protein interactions. To access oligomeric species, we used the pathological mutants of α-SYN (A30P, G51D and A53T) which form oligomers with distinct properties. Finally, we generated amyloid fibrils from recombinant α-SYN. Binding to oligomers and fibrils was measured by two-color coincidence detection (TCCD) on a single molecule spectroscopy setup. Overall, we demonstrate that LB components are recruited to specific steps in the aggregation of α-SYN, uncovering future targets to modulate aggregation in synucleinopathies.

28 February 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
ACAlexandre Chappard
Alexandre Chappard
CLCraig Leighton
Craig Leighton
RSRebecca S. Saleeb
Rebecca S. Saleeb
KJKiani Jeacock
Kiani Jeacock
SBSarah R. Ball
Sarah R. Ball
MHMathew Horrocks
Mathew Horrocks
Protein misfolding and aggregation into oligomeric and fibrillar structures is a common feature of many neurogenerative disorders. Single‐molecule techniques have enabled characterization of these lowly abundant, highly heterogeneous protein aggregates, previously inaccessible using ensemble averaging techniques. However, they usually rely on the use of recombinantly‐expressed labeled protein, or on the addition of amyloid stains that are not protein‐specific. To circumvent these challenges, we have made use of a high affinity antibody labeled with orthogonal fluorophores combined with fast‐flow microfluidics and single‐molecule confocal microscopy to specifically detect α‐synuclein, the protein associated with Parkinson's disease. We used this approach to determine the number and size of α‐synuclein aggregates down to picomolar concentrations in biologically relevant samples.

17 November 2023 in Science Advances
Verified
Journal Article
Open access
RSRebecca S. Saleeb
Rebecca S. Saleeb
CLCraig Leighton
Craig Leighton
JLJi-Eun Lee
Ji-Eun Lee
JOJudi O’sHaughnessy
Judi O’sHaughnessy
KJKiani Jeacock
Kiani Jeacock
MHMathew Horrocks
Mathew Horrocks
Protein misfolding and aggregation is a characteristic of many neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease. The oligomers generated during aggregation are likely involved in disease pathogenesis and present promising biomarker candidates. However, owing to their small size and low concentration, specific tools to quantify and characterize aggregates in complex biological samples are still lacking. Here, we present single-molecule two-color aggregate pulldown (STAPull), which overcomes this challenge by probing immobilized proteins using orthogonally labeled detection antibodies. By analyzing colocalized signals, we can eliminate monomeric protein and specifically quantify aggregated proteins. Using the aggregation-prone alpha-synuclein protein as a model, we demonstrate that this approach can specifically detect aggregates with a limit of detection of 5 picomolar. Furthermore, we show that STAPull can be used in a range of samples, including human biofluids. STAPull is applicable to protein aggregates from a variety of disorders and will aid in the identification of biomarkers that are crucial in the effort to diagnose these diseases.

28 March 2023 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Open access
KJKiani Jeacock
Kiani Jeacock
ACAlexandre Chappard
Alexandre Chappard
KGKelly J. Gallagher
Kelly J. Gallagher
CMC. Logan Mackay
C. Logan Mackay
DKDavid P. A. Kilgour
David P. A. Kilgour
DCDavid Clarke
David Clarke

19 October 2022 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
MCMinee L. Choi
Minee L. Choi
ACAlexandre Chappard
Alexandre Chappard
BSBhanu P. Singh
Bhanu P. Singh
CMCatherine Maclachlan
Catherine Maclachlan
MRMargarida Rodrigues
Margarida Rodrigues
SGSonia Gandhi
Sonia Gandhi